同仁堂：11月28日召开董事会会议

Group 1 - The core point of the article is that Tongrentang (SH 600085) announced the convening of its 17th board meeting on November 28, 2025, to discuss related party transactions regarding brand licensing [1] - For the first half of 2025, Tongrentang's revenue composition is as follows: pharmaceutical manufacturing accounts for 67.17%, pharmaceutical commerce for 61.98%, other businesses for 0.55%, and other categories for 0.45%, with offsets accounting for -30.16% [1] - As of the report date, Tongrentang's market capitalization is 45.9 billion yuan [1]